117 related articles for article (PubMed ID: 22800904)
21. Angiotensin converting enzyme inhibitors for prevention of new-onset type 2 diabetes mellitus: a meta-analysis of 72,128 patients.
Geng DF; Jin DM; Wu W; Liang YD; Wang JF
Int J Cardiol; 2013 Sep; 167(6):2605-10. PubMed ID: 22809536
[TBL] [Abstract][Full Text] [Related]
22. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
Tandon N; Ali MK; Narayan KM
Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
[TBL] [Abstract][Full Text] [Related]
23. Should all patients at high cardiovascular risk receive renin-angiotensin system blockers?
Volpe M
QJM; 2012 Jan; 105(1):11-27. PubMed ID: 22011630
[TBL] [Abstract][Full Text] [Related]
24. A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure.
Savarese G; Costanzo P; Cleland JG; Vassallo E; Ruggiero D; Rosano G; Perrone-Filardi P
J Am Coll Cardiol; 2013 Jan; 61(2):131-42. PubMed ID: 23219304
[TBL] [Abstract][Full Text] [Related]
25. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
26. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
Ravera M; Deferrari L; Ratto E; Vettoretti S; Parodi D; Deferrari G
Ital Heart J Suppl; 2003 Mar; 4(3):210-6. PubMed ID: 12784755
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.
Epstein BJ; Gums JG
Ann Pharmacother; 2005 Mar; 39(3):470-80. PubMed ID: 15701766
[TBL] [Abstract][Full Text] [Related]
28. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
Saha SA; Molnar J; Arora RR
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
[TBL] [Abstract][Full Text] [Related]
29. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.
Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M
J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836
[TBL] [Abstract][Full Text] [Related]
30. Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials.
Allemann S; Diem P; Egger M; Christ ER; Stettler C
Curr Med Res Opin; 2006 Mar; 22(3):617-23. PubMed ID: 16574044
[TBL] [Abstract][Full Text] [Related]
31. ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery.
Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Gentile G; Reboldi G
Am J Cardiovasc Drugs; 2010; 10(4):247-59. PubMed ID: 20653331
[TBL] [Abstract][Full Text] [Related]
32. Effects of intensive glucose control on incidence of cardiovascular events in patients with type 2 diabetes: a meta-analysis.
Zhang CY; Sun AJ; Zhang SN; Wu CN; Fu MQ; Xia G; Wang KQ; Zou YZ; Ge JB
Ann Med; 2010 May; 42(4):305-15. PubMed ID: 20429797
[TBL] [Abstract][Full Text] [Related]
33. Do angiotensin II receptor blockers increase the risk of myocardial infarction?
Verdecchia P; Angeli F; Gattobigio R; Reboldi GP
Eur Heart J; 2005 Nov; 26(22):2381-6. PubMed ID: 16081468
[TBL] [Abstract][Full Text] [Related]
34. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
Saha SA; Molnar J; Arora RR
Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
[TBL] [Abstract][Full Text] [Related]
35. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.
Bangalore S; Kumar S; Lobach I; Messerli FH
Circulation; 2011 Jun; 123(24):2799-810, 9 p following 810. PubMed ID: 21632497
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
Dahabreh IJ; Economopoulos K
Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
[TBL] [Abstract][Full Text] [Related]
37. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns.
Haffner SM
Am J Med; 2006 May; 119(5 Suppl 1):S3-9. PubMed ID: 16563945
[TBL] [Abstract][Full Text] [Related]
38. Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials.
Flaa A; Aksnes TA; Strand A; Kjeldsen SE
Expert Rev Cardiovasc Ther; 2007 May; 5(3):451-61. PubMed ID: 17489670
[TBL] [Abstract][Full Text] [Related]
39. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.
Parving HH; Brenner BM; McMurray JJ; de Zeeuw D; Haffner SM; Solomon SD; Chaturvedi N; Ghadanfar M; Weissbach N; Xiang Z; Armbrecht J; Pfeffer MA
Nephrol Dial Transplant; 2009 May; 24(5):1663-71. PubMed ID: 19145003
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular and mortality risk in elderly Medicare beneficiaries treated with olmesartan versus other angiotensin receptor blockers.
Graham DJ; Zhou EH; McKean S; Levenson M; Calia K; Gelperin K; Ding X; MaCurdy TE; Worrall C; Kelman JA
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):331-9. PubMed ID: 24277678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
